Medibank Private (ASX:MPL) share price dips despite 27% profit boost

The Medibank Private Limited (ASX:MPL) share price is down today, despite the release of strong half-yearly results for FY20 from the insurer.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) shares are under pressure today following the release of the insurer's half-yearly results for FY21.

At the time of writing, the Medibank share price has dipped to $2.83, down 2.08%.

What did Medibank announce today?

The private health insurance provider announced a net profit after tax of $226.4 million for the 6 months ending 31 December 2020 – a 27.3% increase compared to the prior corresponding period (pcp).

The company attributed the increased profit primarily to a net gain of 49,000 policy holders over the period. 17,600 of these new customers signed up for Medibank-branded insurance itself.

"This is the first time we have grown the Medibank brand in any 6-month period since 2013 and this trend has continued into February," the company said in a media release today.

Medibank's results stand in stark contrast to the private health insurance industry at large. According to the Australian Prudential Regulatory Authority, industry profitability was down by 2 percentage points on the pcp — driven largely by the COVID-19 pandemic.

The pandemic led many private health insurance providers, including Medibank, to postpone premium increases for 6 months. Medibank stated the postponement cost the company $109 million in revenue. Despite this, revenue from premiums did rise 0.3% to $3.3 billion.

In further good news for shareholders, net claims expenses also decreased by 0.8% compared to the pcp, or $24.1 million. Gross claims fell by 1.8%, including a $99 million COVID-related reduction in claims and risk equalisation payable for the period. Underlying claims, adjusted for COVID impacts and provision movements, rose by 2.6%.

The company announced a dividend of 5.8 cents per share fully franked.

Medibank CEO to retire

Along with today's financial announcements, Medibank Private CEO Craig Drummond announced he is retiring from the position come 30 June.

Mr Drummond made the following comments about the results release and his impending retirement.

"Pleasingly Medibank is on a clear strategic path to grow the private health insurance business at a faster rate and continue its transformation into a broader healthcare company."

"Leading Medibank through this transition has been incredibly rewarding."

The Medibank share price during Mr Drummond's tenure saw a modest decline – starting around $3 when he first started while opening this morning at $2.89. During his time, Medibank shares hit a high of $3.65 and a low of $2.33.

Future outlook

Medibank is continuing its investment in healthcare. The company also announcing an expansion of its no gap joint replacement pilot into 6 regions. The pilot is a part of the company's investment into a 'short-stay model of care' program – a long-term venture aiming to reduce hospital-related expenses for both customer and company.

As of 15 February, Medibank Private is still the leading private health insurance company in Australia with a 26.9% market share and 3.7 million customers, according to comparison site ComparingExpert.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »